KATHY HINTZ: Open Payments
NPI 1114978004 · BAYOU LA BATRE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,729 in 84 payments from 18 companies in 2025. Trend: 2023 $1,761 · 2024 $730 · 2025 $1,729
Food & beverage: $1,729
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 16 | $344 |
| Alkermes, Inc. | 11 | $331 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $208 |
| Corium, LLC | 8 | $140 |
| Otsuka America Pharmaceutical, Inc. | 10 | $135 |
| Supernus Pharmaceuticals, Inc. | 7 | $123 |
| AstraZeneca Pharmaceuticals LP | 2 | $97 |
| Vanda Pharmaceuticals Inc. | 2 | $67 |
| ABBVIE INC. | 2 | $66 |
| Organogenesis Inc. | 2 | $48 |
Products named: INGREZZA, ARISTADA, CAPLYTA, Azstarys, Qelbree, AIRSUPRA, REXULTI, ABILIFY MAINTENA.
Industry payments across AL — which companies pay providers there.
